Ophthalmology
Overview
Ophthalmology is facing significant capacity challenges brought about by the COVID-19 pandemic and ophthalmologists need to plan restoration of cataract surgery, whilst dealing with the challenges of COVID-19 transmission prevention. The ABHI Opthalmology Group is designed to support the sector.
Leadership
- Chair Syed Rashid, Johnson & Johnson Vision
- Vice Chair Emily Paynton, Alcon
Achievements
- Convened meeting with the the Royal College of Ophthalmologists and industry.
- Industry’s objectives on educational and clinical training highlighted and clinical requirement requested.
- Individual manufacturers educational offering presented to the Royal College of Ophthalmologists bilaterally.
Priorities
- Ongoing engagement with the clinical community around ophthalmology service provision.
- Identify the Royal College of Ophthalmologists requirements for support on the restart of ophthalmology.
- Engagement with GIRFT regarding the GIRFT ophthalmology Report.
Click here to view the latest updates, minutes and future meeting dates for the group.
To join the ABHI Ophthalmology group, contact luella.trickett@abhi.org.uk
"This is a unique opportunity moving out of the pandemic with a world class vaccination programme, that the Ophthalmology group can effectively engage external key stakeholders to look at ways to collectively manage the challenge of the backlog of elective surgery. This will build trust to have a seamless partnership with the working group and create value for our external stakeholders."
Syed Rashid, Director of Market Access & Sales Training, Johnson & Johnson Vision & Chair, Ophthalmology Group